SOD2 and medulloblastoma: In this assessment, pediatric medulloblastoma patients who received cisplatin chemotherapy and had the C-allele of SOD2 rs4880, which has been associated with noise-induced hearing loss 16, had an increased susceptibility to ototoxicity.